ImportRefusal LogoImportRefusal

Silky Pleasure Cosmetic

⚠️ Moderate Risk

FEI: 3008132860 • Paris • FRANCE

FEI

FEI Number

3008132860

📍

Location

Paris

🇫🇷

Country

FRANCE
🏢

Address

Unknown, , Paris, , France

Moderate Risk

FDA Import Risk Assessment

38.6
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

8
Total Refusals
5
Unique Violations
3/4/2016
Latest Refusal
8/5/2011
Earliest Refusal

Score Breakdown

Violation Severity
65.7×40%
Refusal Volume
35.3×30%
Recency
0.0×20%
Frequency
17.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3352×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

Refusal History

DateProductViolationsDivision
3/4/2016
53JC99OTHER PERSONAL CLEANLINESS PRODUCTS (NOT ANTIPERSPIRANT), N.E.C.
75UNAPPROVED
Minneapolis District Office (MIN-DO)
11/26/2014
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
11/26/2014
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
9/30/2013
55RY55SODIUM CHLORIDE (PHARMACEUTIC NECESSITY - TONICITY AGENT)
333LACKS FIRM
335LACKS N/C
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/12/2012
53EC99OTHER HAIR PREPARATIONS, NON-COLORING), N.E.C.
471CSTIC LBLG
New Orleans District Office (NOL-DO)
6/12/2012
66YDY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/12/2012
62SDY99ANTI-SEBORRHEIC N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/5/2011
66VBU99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
335LACKS N/C
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Silky Pleasure Cosmetic's FDA import refusal history?

Silky Pleasure Cosmetic (FEI: 3008132860) has 8 FDA import refusal record(s) in our database, spanning from 8/5/2011 to 3/4/2016.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Silky Pleasure Cosmetic's FEI number is 3008132860.

What types of violations has Silky Pleasure Cosmetic received?

Silky Pleasure Cosmetic has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Silky Pleasure Cosmetic come from?

All FDA import refusal data for Silky Pleasure Cosmetic is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.